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TNF-α levels in blood were assessed before, immediately 
after, and 1, 2, 3, and 5 days after exercise.
Results MVC was significantly higher in the EPA group 
than in the PL group at 2–5 days after exercise (p < 0.05). 
ROM was also significantly greater in the EPA group than 
in the PL group at 1–5 days after exercise (p < 0.05). At 
only 3 days after exercise, muscle soreness of the brachialis 
was significantly greater in the PL group than in the EPA 
group (p < 0.05), with a concomitant increase in serum 
IL-6 levels in the PL group.
Conclusion Eight-week EPA + DHA supplementation 
attenuates strength loss and limited ROM after exercise. 
The supplementation also attenuates muscle soreness and 
elevates cytokine level, but the effect is limited.
Keywords Eicosapentaenoic acid · Docosahexaenoic 
acids · Lengthening contractions · Supplement · Muscle 
dysfunction · Muscle strength
Abbreviations
AA  Arachidonic acid
ANOVA  Analysis of variance
BCAA  Branched-chain amino acids
CK  Creatine kinase
DGLA  Dihomo-gamma-linolenic acid
DHA  Docosahexaenoic acid
DOMS  Delayed-onset muscle soreness
EPA  Eicosapentaenoic acid
IL-6  Interleukin-6
Mb  Myoglobin
MVC  Maximal voluntary isometric contraction
PL  Placebo
RBC  Red blood cell
ROM  Range of motion
RPE  Rating of perceived exertion
Abstract 
Purpose This study investigated the effect of eicosa-
pentaenoic and docosahexaenoic acids-rich fish oil 
(EPA + DHA) supplementation on eccentric contraction-
induced muscle damage.
Methods Twenty-four healthy men were randomly 
assigned to consume the EPA + DHA supplement (EPA, 
n = 12) or placebo (PL, n = 12) by the double-blind 
method. Participants consumed EPA + DHA or placebo 
supplement for 8 weeks prior to exercise and continued 
it until 5 days after exercise. The EPA group consumed 
EPA + DHA-rich fish oil containing 600 mg EPA and 
260 mg DHA per day. Subjects performed five sets of six 
maximal eccentric elbow flexion exercises. Changes in 
the maximal voluntary contraction (MVC) torque, range 
of motion (ROM), upper arm circumference, muscle sore-
ness as well as serum creatine kinase, myoglobin, IL-6, and 
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TNF-α  Tumor necrosis factor-alpha
VAS  Visual analog scale
Introduction
Resistance exercise performed two to three times per week 
to increase muscle strength and mass is recommended by 
the American College of Sports Medicine (Garber et al. 
2011). However, excessive eccentric contractions (ECCs) 
cause the development of delayed-onset muscle soreness 
(DOMS), the reduction of maximal strength, limitation of 
range of motion (ROM), and muscle swelling (Clarkson 
et al. 1992). DOMS has been shown to peak 1–3 days after 
ECC before resolving after approximately 1 week (Chen 
et al. 2011). DOMS is one of the symptoms of muscle dam-
age and demonstrates no relationship between DOMS and 
other indicators of muscle damage such as MVC, ROM, 
circumference, and serum CK) (Nosaka et al. 2002).
ECC-induced muscle damage is defined as morpho-
logical changes in the sarcomeres and endomysium and 
inflammatory responses in muscle fibers and connective 
tissues (Peake et al. 2005). Increase in serum myoglobin 
(Mb) and creatine kinase (CK) levels have been shown to 
be associated with damaged muscle tissue (Clarkson et al. 
1992). In addition, a number of inflammatory cytokines, 
including tumor necrosis factor-α (TNF-α) and interleu-
kin-6 (IL-6), are produced in response to ECCs (Clarkson 
et al. 1992; Ostrowski et al. 1999; Phillips et al. 2003). 
TNF-α is released from damaged tissue, which appears to 
relate to inflammation (Dennis et al. 2004). In addition, 
IL-6 is a known trigger of anti-inflammatory cytokines, 
and exercise-induced IL-6 is also defined as anti-inflam-
matory cytokine and shows improved insulin resistance 
after exercise (Pedersen and Fischer 2007; Panza et al. 
2015).
As fish oils containing rich omega-3 polyunsaturated 
fatty acids are known to have anti-inflammatory effects, 
they were expected to inhibit muscle damage following 
exercise (Gray et al. 2014; Jouris et al. 2011; Tartibian et al. 
2011). Eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) are major fatty acids classified as omega-3 pol-
yunsaturated fatty acids. Numerous scientists have reported 
the various physiological functions of EPA and DHA 
including lipid metabolism, anti-inflammation, and cogni-
tive function (Calder 2015; Eslick et al. 2009; Jiao et al. 
2014).
Previous studies have reported the efficacy of EPA 
and DHA supplementation in reducing exercise-induced 
limited ROM, development of DOMS, muscle swell-
ing, increase in serum CK, and IL-6 (DiLorenzo et al. 
2014; Houghton and Onambele 2012; Jouris et al. 2011; 
Tartibian et al. 2009, 2011). In a review article, it has 
been suggested that an ingestion ratio of EPA to DHA 
of approximately 2:1 may be beneficial in counteract-
ing exercise-induced inflammation (Mickleborough 
2013). Taribian et al. (2009, 2011) examined the effects 
of 324 mg/day EPA and 216 mg/day DHA ingestion for 
30 days on muscle damage after 40 min of bench step-
ping. Serum levels of TNF-α after 324 mg/day EPA and 
216 mg/day DHA induced (Tartibian et al. 2011) devel-
opment of DOMS, limited ROM, and significantly inhib-
ited muscle swelling (Tartibian et al. 2009) in response to 
this regimen. From these studies, it appears that EPA and 
DHA attenuate inflammatory cytokines, limited ROM, 
and increased DOMS, CK, and Mb. However, there is 
no study to show the positive effects of EPA and DHA 
on decrease in muscle strength after strenuous exercise. 
Lenn et al. (2002) reported that ingestion of 400 mg/day 
EPA and 270 mg/day DHA for 30 days did not reduce the 
decrease in muscle strength. Taken together, more than 
400 mg/day EPA and 200 mg/day DHA may be needed 
to show the beneficial effect on exercise-induced mus-
cle damage. On the other hand, the amount of EPA and 
DHA is limited to a total of 3000 mg per day for safety 
in humans by the natural medicines comprehensive data-
base (US Food and Drug Administration 2000). From 
the previous studies and considering the safety factor, 
we thought that ingestion of 400–2000 mg/day EPA and 
200–1000 mg/day DHA (ratio of EPA to EHA is approx-
imately 2:1) is needed for the attenuation in muscle 
strength using ECC.
In particular, for the supplementation period, it has been 
reported that the necessary amounts of EPA and DHA 
into the myocardium is satisfied by the ingestion of fish 
oil for 30–60 days (Metcalf et al. 2007). However, previ-
ous studies focused on muscle strength for the period of 
21–30 days (DiLorenzo et al. 2014; Houghton and Onam-
bele 2012; Lenn et al. 2002). In addition, in the majority 
of the previous studies, the effects of omega-3 consump-
tion on exerted torque and work output during exercise are 
uncertain. Therefore, there is a need for studies that evalu-
ate longer periods and larger doses of omega-3 polyun-
saturated fatty acid supplementation for muscular strength, 
including other muscle damage markers after simple joint 
movement by quantifying the exerted torque and work 
output.
We hypothesized that 600 mg/day EPA and 260 mg/
day DHA for 8 weeks would attenuate the maximal 
strength in response to ECC. The aim of the present study 
was to investigate the efficacy of EPA and DHA-rich fish 
oil supplementation for 8 weeks in reducing ECC-induced 
muscle damage, including development of DOMS, limit 
of ROM, muscle swelling, and increased serum levels 
of inflammatory cytokines and muscle damage-related 
proteins.




A total of 24 Japanese healthy men (age, 19.5 ± 0.8 years; 
height, 174.4 ± 6.0 cm; weight, 65.3 ± 7.7 kg; body fat, 
13.3 ± 3.1 %) were recruited for this study. They were 
allergic to fish and resistance training and requested to 
avoid participation in other clinical trials and interventions 
such as massage, stretching, strenuous exercise, excessive 
consumption of food or alcohol, and any supplement or 
medication during the experimental period. All participants 
were provided with detailed explanations of the study pro-
tocol prior to participation and signed an informed consent 
form in accordance with the Declaration of Helsinki before 
being enrolled in this study. This study was approved by 
the Ethics Committee for Human Experiments at Juntendo 
University (ID: 26–113) and has been registered at the Uni-
versity Hospital Medical Information Network Clinical Tri-
als Registry (UMIN-CTR, identifier: UMIN000016149). 
The estimation was based on the effect size of 1, alpha 
level of 0.05, and a power (1−b) of 0.80 for the comparison 
EPA group and PL group following ECC, which showed 
that at least ten participants were necessary (G*power, ver-
sion 3.0.10).
Study design
The study was performed by a double-blind, placebo-
controlled, parallel-group trial design. All subjects 
were randomly assigned to two groups in such a man-
ner as to minimize the inter-group differences in age, 
body fat, BMI, and maximal voluntary isometric con-
traction (MVC) torque, and they consumed either 
EPA and DHA (EPA, n = 12; age, 19.4 ± 0.7 years; 
height, 174.4 ± 5.6 cm; weight, 64.3 ± 7.7 kg; body fat, 
13.0 ± 3.5 %; MVC, 58.6 ± 14.9 Nm) or placebo (PL, 
n = 12; age, 19.5 ± 0.8 years; height, 174.3 ± 6.7 cm; 
weight, 66.2 ± 8.0 kg; body fat, 13.6 ± 2.8 %; MVC, 
58.0 ± 11.6 Nm) for 8 weeks prior to the exercise experi-
ment and continued it until 5 days after the exercise. 
Sequence allocation concealment and blinding to subjects 
and researchers were maintained during treatment. Since it 
has been reported that the compensation of EPA and DHA 
concentration into the myocardium is needed for the inges-
tion of fish oil for 30–60 days (Metcalf et al. 2007), the 
duration of the total ingestion period was 62 days (includ-
ing the exercise day). On the day of exercise testing, MVC 
torque, range of motion of the elbow joint (ROM), upper 
arm circumference, muscle soreness assessed by a visual 
analog scale (VAS), and fasting blood samples were meas-
ured in the non-dominant arm before exercise. Immediately 
after baseline measurements, ECC in the non-dominant 
arm as with the other measurement was performed in each 
subject. All measurements were performed immediately 
before, immediately after, and 1, 2, 3, and 5 days after exer-
cise. Measurements were performed in a room maintained 
at 24−26 °C. In addition, we surveyed the nutrition status 
of all subjects prior to supplement consumption (8 weeks 
before the exercise experiment) and after experimental 
testing of the food frequency questionnaire based on food 
groups (FFQg, version 3.5, Kenpakusha, Tokyo, Japan). 
The outcome measures were MVC torque, ROM, upper 
arm circumference, muscle soreness, and blood serum 
markers. In addition, we also measured serum fatty acids 
including EPA, DHA, arachidonic acid (AA), and dihomo-
gamma-linolenic acid (DGLA). Based on the two baseline 
measures of MVC torque, ROM, upper arm circumference, 
and muscle soreness (before exercise and different day), the 
test–retest reliability of the measures was examined.
Supplements
The EPA group consumed eight 300 mg EPA and 130 mg 
DHA-rich fish oil softgel capsules (Nippon Suisan Kai-
sha Ltd., Tokyo, Japan) per day (containing 600 mg EPA 
and 260 mg DHA in a total of 2400 mg). The PL group 
consumed eight 300 mg corn oil softgel capsules (Nippon 
Suisan Kaisha Ltd., Tokyo, Japan) per day (not containing 
EPA and DHA in a total of 2400 mg). Subjects consumed 
the supplements 30 min after meals with water.
Eccentric contractions
Each subject was seated in the chair of an isokinetic 
dynamometer (Biodex Multi-Joint System 3, NY, USA) 
with one arm set at a shoulder joint angle of 45° flexion, 
and the elbow joint aligned with the rotation axis of the 
isokinetic dynamometer. The lever arm of the isokinetic 
dynamometer was secured to the wrist of subjects in a supi-
nated position. ECC consisted of five sets of six maximal 
voluntary eccentric contractions of the elbow flexors at 
a constant velocity of 30°/s for the range of motion from 
90° flexion to 0° (full extension). Subjects were verbally 
encouraged to maximally resist throughout the ROM for 
3 s. The isokinetic dynamometer returned the arm to the 
90° flexed position at a constant velocity of 30°/s, provid-
ing 3 s passive recovery between contractions. The meas-
urements of torque produced during eccentric contrac-
tions were stored in a computer connected to the isokinetic 
dynamometer, and work output and peak torque were cal-
culated later. These measurements were based on a previ-
ous study (Chen et al. 2011).
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Maximal voluntary isometric contraction (MVC) 
torque
MVC torque was measured on the same apparatus and 
positioning as described for eccentric exercise. Subjects 
performed two 5-s MVCs at 90° elbow joint angle with a 
15-s rest between contractions. The peak torque of the two 
contractions was used as the MVC torque as described in 
our previous study (Tsuchiya et al. 2015). The test–retest 
reliability of the MVC measures based on coefficient of 
variation (CV) was 3.9 %.
Range of motion (ROM) of the elbow joint
To examine the elbow joint ROM, two elbow joint angles 
(extended and flexed joint angles) were measured using a 
goniometer (Takase Medical, Tokyo, Japan). The extended 
joint angle was recorded when subjects attempted to fully 
extend the joint, with the elbow held by their side and the 
hand in supination. The flexed joint angle was determined 
when subjects attempted to fully flex the joint from an equally 
fully extended position with the hand supinated. ROM was 
calculated by subtracting the flexed joint angle from the 
extended joint angle (Tsuchiya et al. 2015). The test–retest 
reliability of the ROM measures based on CV was 4.2 %.
Upper arm circumference
Upper arm circumference was assessed at 3, 5, 7, 9, and 11 cm 
above the elbow joint using a tape measure while subjects 
were standing with the arms relaxed by their side. The mean 
value of five measurements was used for analysis (Nosaka 
et al. 2005). Measurement marks were maintained during the 
experimental period using a semi-permanent ink marker, and 
a well-trained investigator took the measurements. The aver-
age value of three measurements was used for further analysis. 
The test–retest reliability of the circumference measurements 
for the five sites based on CV was 2.2–3.4 %.
Muscle soreness of elbow flexors
Muscle soreness was assessed using a 100-mm VAS in 
which 0 indicates ‘‘no pain’’ and 100 is the ‘‘worst pain 
imaginable’’. Each subject was asked to indicate the pain 
level on the scale when an investigator palpated the biceps 
brachii, brachialis, or brachioradialis, respectively, using a 
thumb while subjects relaxed with their arms in the natural 
position. All tests were conducted by the same investigator 
who had been trained to apply the same pressure over time 
and between subjects. The test–retest reliability of the VAS 
measures for the three muscles based on CV was 0–4.7 %.
Blood samples
Subjects fasted for 8 h prior to blood samples being taken 
from the forearm by a trained doctor. Blood samples 
were allowed to clot at room temperature (25 °C) and 
then centrifuged at 3000 rpm for 10 min at 4 °C. Serum 
was extracted and stored at −20 °C until analysis. The 
serum levels of CK, Mb, IL-6, TNF-α, and four fatty 
acids (DGLA, AA, EPA, DHA) were measured. Serum 
CK levels were measured according to the Japan Society 
of Clinical Chemistry Standardized Method. Serum Mb 
and IL-6 levels were measured by chemiluminescence 
enzyme immunoassay (CLEIA), and serum TNF-α levels 
were measured using an enzyme-linked immunosorbent 
assay (ELISA). Serum fatty acid levels were measured 
using gas chromatography spectrometry (GC). The test–
retest reliability of the CK, Mb, IL-6, and TNF-α meas-
urements based on CV was 3.8, 2.8, 2.9, and 11.4 %, 
respectively. Also, that of the DGLA, AA, EPA, and DHA 
measurements based on CV were 5.6, 4.9, 5.1, and 6.6 %, 
respectively.
Statistical analyses
All analyses were performed using SPSS Statistics soft-
ware version 20.0 (IBM, Armonk, NY). All variables are 
expressed as means ± standard deviations (SD). All data 
were confirmed within the normal distribution by Kol-
mogorov–Smirnov test. MVC, ROM, upper arm circum-
ference, muscle soreness, and blood samples over time 
were compared between the PL and EPA groups by a two-
way repeated measure analysis of variance (ANOVA). 
When a significant interaction or time effect was found, 
Bonferroni’s correction was performed as a post hoc 
test. A p value of <0.05 was considered to be statistically 
significant.
Results
Nobody dropped out during this study period. As a 
result of food frequency questionnaire, no difference in 
nutrition status was observed between the EPA group 
(energy, 2578.2 ± 610.7 kcal; protein, 82.0 ± 27.8 g; 
fat, 88.7 ± 22.2 g; carbohydrate, 348.5 ± 94.3 g; 
omega3 fatty acid, 2.6 ± 1.4 g) and PL group (energy, 
2413.3 ± 948.4 kcal; protein, 76.2 ± 26.1 g; fat, 
89.6 ± 45.8 g; carbohydrate, 313.9 ± 112.5 g; omega3 
fatty acid, 2.3 ± 1.0 g) before the intake of supplements. 
The nutrition status of these parameters had not changed 
during the experimental period.
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Eccentric contractions
No significant difference in work output (Fig. 1a) or peak 
torque (Fig. 1b) during any set of ECC was observed 
between the two groups.
Maximal voluntary isometric contraction torque
MVC torque value was indicated by relative change compared 
with pre ECC value as 100 % (EPA group, 58.6 ± 14.9 Nm; 
PL group, 58.0 ± 11.6 Nm). MVC torque (Fig. 2a) in the PL 
group significantly decreased from immediately after to 5 days 
after exercise compared with pre-exercise levels (post, day 1, 
day 2, day 3, and day 5, p < 0.05). MCV torque in the EPA 
group decreased immediately after exercise compared with 
pre-exercise levels (p < 0.05). MVC was significantly higher 
in the EPA group than in the PL group at 2, 3, and 5 days 
after exercise [day 2; PL 78.4 ± 10.4 %, EPA 95.5 ± 20.1 %, 
Cohen’s d (d) = 1.04, 95 % confidence interval (CI) 
0.15–1.85, day 3; PL 82.6 ± 6.8 %, EPA 98.7 ± 15.0 %, 
a b
Fig. 1  Changes (mean ± SD) in total work (a) and peak torque (b) over five sets of six maximal eccentric contractions in the placebo and EPA 
groups. n.s. not significant
a b c
d e
Fig. 2  Changes (mean ± SD) in maximal voluntary isometric con-
traction (MVC) torque (a), range of motion (ROM) (b), circumfer-
ence (c), myoglobin (d), and creatine kinase (e) before (pre), immedi-
ately after (post), and 1, 2, 3, and 5 days after eccentric contractions 
in the placebo group and EPA group. *p < 0.05 a significant differ-
ence between groups, †p < 0.05 a significant difference from pre-
exercise value in the EPA group, #p < 0.05 a significant difference 
from pre-exercise value in the placebo group. n.s. not significant
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d = 1.39, CI 0.45–2.22, and day 5; PL 85.1 ± 11.4 %, EPA 
101.3 ± 14.0 %, d = 1.27, CI 0.35–2.10, p < 0.05].
Range of elbow motion
Figure 2b showed the values of ROM by relative change com-
pared with pre ECC value as 100 % (EPA group, 127.3° ± 7.5°; 
PL group, 130.6° ± 10.4°). Although no significant decrease 
in elbow ROM from pre-exercise values was observed in 
the EPA group, a significant decrease in the PL group was 
observed immediately after exercise (reduction of 18.0 ± 6.1 %, 
p < 0.05) and remained lower than baseline levels at 1, 2, and 
3 days (p < 0.05). Elbow ROM in the EPA group was sig-
nificantly greater than that in the PL group from immediately 
after exercise to 3 days after exercise (post; PL 84.0 ± 7.2 %, 
EPA 96.4 ± 10.9 %, d = 1.88, CI 0.87–2.77, day 1; PL 
89.0 ± 6.3 %, EPA 99.0 ± 8.1 %, d = 1.50, CI 0.55–2.35, day 
2; PL 88.0 ± 7.1 %, EPA 97.6 ± 8.8 %, d = 1.11, CI 0.22–1.93, 
and day 3; PL 88.5 ± 10.9 %, EPA 99.6 ± 6.0 %, d = 1.01, CI 
0.13–1.83, p < 0.05). ROM was also evaluated as absolute values 
in degrees. At post-ECC, days 2 and 3, elbow ROM degree was 
significantly different between the two groups. The degree of 
ROM indicated 111.5° ± 14.6° vs 120.3° ± 13.2° at post-ECC, 
116.4° ± 10.1° vs 121.6° ± 9.5° at day 2, and 116.7° ± 11.7° vs 
125.0° ± 7.2° at day 3 (PL group vs EPA group, respectively).
Upper arm circumference
Upper arm circumference value was indicated by the change 
rate compared with the pre-ECC value as 100 % (EPA group, 
25.0 ± 1.5 cm; PL group, 26.0 ± 1.7 cm). No significant dif-
ference in the upper arm circumference from pre-exercise 
values was observed in either group (EPA, 101.8 ± 1.1 %; 
PL, 101.3 ± 1.9 %). No significant difference between the 
two groups was observed at any time point (Fig. 2c).
Muscle soreness
Greater muscle soreness developed at the biceps brachii and 
brachialis at 1, 2, and 3 days after exercise compared with 
pre-exercise values in the PL group (Fig. 3a, b). In the EPA 
group, greater muscle soreness developed at the biceps bra-
chii at 1, 2, and 3 days after exercise and at the brachialis 
at 2 days after exercise compared with pre-exercise values 
a b
c
Fig. 3  Changes (mean ± SD) in muscle soreness assessed by visual 
analog scale (VAS) for palpation of biceps brachii (a), brachialis (b) 
and brachioradialis (c) before (pre), immediately after (post), and 
1, 2, 3, and 5 days after eccentric contractions in the placebo group 
and EPA group. *p < 0.05 a significant difference between groups, 
†p < 0.05 a significant difference from pre-exercise value in the EPA 
group, #p < 0.05 a significant difference from the pre-exercise value 
in the placebo group. n.s. not significant
1185Eur J Appl Physiol (2016) 116:1179–1188 
1 3
(Fig. 3a, b). Significantly greater muscle soreness at the 
brachialis was observed in the PL group compared with the 
EPA group at 3 days after exercise (PL, 34.2 ± 15.3 mm vs 
EPA, 12.7 ± 16.5 mm, d = 1.46, CI 0.52–2.31, p < 0.05). 
On the other hand, no significant increase in muscle sore-
ness at the brachioradialis from pre-exercise values was 
observed in either group, with no significant difference 
between groups observed at any time point (Fig. 3c).
Blood analyses
No significant differences in AA and DHA from pre-exer-
cise values were observed in either group, with no signifi-
cant differences between groups at any time point (data not 
shown). No significant difference in DGLA from pre-exer-
cise values was observed in either group; however, signifi-
cantly higher levels were observed in the PL group than 
the EPA group at 2 and 3 days after exercise (p < 0.05). 
On the other hand, EPA was significantly higher in the 
EPA group than in the PL group from before exercise to 
3 days after exercise (pre; d = 0.52, CI 0.31–1.31, post; 
d = 0.50, CI 0.33–1.29, day 1; d = 0.80, CI 0.06–1.60, 
day 2; d = 0.65, CI 0.19–1.44, and day 3; d = 0.64, CI 
0.20–1.44, p < 0.05).
Although serum IL-6 levels in the PL group were sig-
nificantly increased at 3 days after exercise compared with 
pre-exercise vales (Fig. 4a, p < 0.05), no significant differ-
ence in serum IL-6 levels after exercise compared with pre-
exercise values was observed in the EPA group. Serum IL-6 
levels were significantly higher in the PL group than the 
EPA group at 3 days after exercise (PL, 1.8 ± 1.1 μg/ml vs 
EPA, 0.8 ± 0.4 μg/ml, d = 1.17, CI 0.27–1.99, p < 0.05). 
In contrast, no significant difference in serum TNF-α lev-
els after exercise compared with pre-exercise values was 
observed in either group, with no significant difference 
observed between groups (Fig. 4b).
Serum Mb levels in the PL group were significantly 
increased at 3 days after exercise compared with pre-exer-
cise values (Fig. 2d, p < 0.05); however, no significant dif-
ference after exercise compared with pre-exercise values 
was observed in the EPA group. No significant differences 
in serum CK levels after exercise compared with pre-exer-
cise values were observed in either group, with no signifi-
cant difference observed between groups (Fig. 2e).
Discussion
The present study evaluated the efficacy of 8 weeks of 
eicosapentaenoic and docosahexaenoic acid-rich fish oil 
supplementation in reducing muscle damage following 
ECC. The results demonstrate that the group with EPA 
and DHA acids-rich fish oil supplementation attenuated 
reductions of muscle torque loss and limited ROM. The 
supplementation also attenuated DOMS in brachialis 
and increased serum IL-6 levels at only day 3 after ECC. 
There were no changes in muscle swelling, DOMS in 
biceps brachii and brachioradialis, total work and peak 
torque during ECC, and muscle damage-related proteins. 
Especially, we first found the possibility that EPA and 
DHA supplementation could reduce the deficit in muscu-
lar strength after ECC. This result supports our original 
hypothesis.
No significant differences in peak torque or total work 
during ECC were observed between the EPA and PL 
groups. Twelve-week omega-3 polyunsaturated fatty acid 
supplementation (EPA: 2400 mg/day; DHA: 1200 mg/
day) increased red blood cell (RBC) deformability as a 
a b
Fig. 4  Changes (mean ± SD) in serum concentrations of IL-6 (a) 
and TNF-α (b) before (pre), immediately after (post), and 1, 2, 3, 
and 5 days after eccentric contractions in the placebo group and EPA 
group. *p < 0.05 a significant difference between groups, #p < 0.05 a 
significant difference from pre-exercise value in the placebo group. 
n.s. not significant
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consequence of incorporation of omega-3 polyunsaturated 
fatty acid into RBC membrane phospholipids (Anders-
son et al. 2002). Increased RBC deformability may lead 
to enhanced oxygen delivery to skeletal muscle with sub-
sequent improvements in exercise performance (Mickle-
borough 2013). The result of the present study found no 
positive effects of omega-3 polyunsaturated fatty acid sup-
plementation on the exercise performance. However, in a 
study on rats, an 8-week diet rich in DHA was associated 
with decreased fatigue during repetitive twitch contractions 
in vivo (Peoples and McLennan 2014). Data from animal 
studies suggest that omega-3 polyunsaturated fatty acids 
may play a beneficial role in improving the exercise per-
formance. Further studies are required to investigate the 
effects of omega-3 polyunsaturated fatty acids on the mag-
nitude of muscle fatigue produced by higher numbers of 
muscle contractions.
Our study first demonstrated that the possibility of EPA 
and DHA supplementation has a positive effect on MVC 
torque following eccentric exercise. The effects of EPA 
and DHA supplementation on strength loss after ECC 
have been controversial. Houghton and Onambele (2012) 
evaluated a resistance exercise for the lower limbs after 
360 mg/day ingestion of EPA over 3 weeks and demon-
strated no significant differences in muscle strength reduc-
tion between the EPA and placebo groups. In addition, 
DiLorenzo et al. (2014) showed that there was no effect 
on ECC-induced MVC reduction with 2000 mg/day DHA 
for 28 days and Lenn et al. (2002) reported no significant 
differences in muscle strength reduction with 400 mg/day 
EPA and 270 mg/day DHA for 30 days. The present study 
involved the ingestion of larger concurrent doses of EPA 
and DHA for twice the time as seen in Lenn’s study over a 
long period. Therefore, we suggested that ingestion of both 
600 mg/day EPA and 260 mg/day DHA over an 8-week 
period would be necessary to show a positive effect for 
MVC loss after exercise.
Temporal strength losses following ECC are assumed 
to be due to excitation–contraction coupling failure (War-
ren et al. 1993). Although it was not possible to fully elu-
cidate the mechanisms underlying this effect, we speculate 
that EPA and DHA supplementation has utility in protect-
ing muscle cell membrane. Helge et al. (2001) reported that 
the total proportion of omega-3 polyunsaturated fatty acid 
in muscle cellular membrane was significantly increased 
after the ingestion of fish oil. Consumed omega-3 poly-
unsaturated fatty acids are incorporated into phospholipid, 
a major component of the cell membrane, and have been 
reported to inhibit the effects of inflammation and reactive 
oxygen species (Ling et al. 1998). Therefore, the incorpora-
tion of omega-3 polyunsaturated fatty acids into the mus-
cle cell membrane alleviates tissue inflammation, thereby 
suppressing the disruption of neuromuscular junction and 
postsynaptic electrical transition.
The ROM limitation in the EPA group was significantly 
lower than that in the PL group in the present study. Since 
we speculate that EPA and DHA have a role in the protec-
tion of muscle cell membrane, it might attenuate the lim-
ited ROM, because the ROM following ECC has been 
attributed to inflammatory response within myofibrils lead-
ing to increases in passive stiffness (Chleboun et al. 1998). 
Tartibian et al. (2009) also demonstrated a decrease in 
ROM following EPA consumption compared with placebo. 
However, Lenn et al. (2002) reported that 30 days ingestion 
of EPA did not ameliorate limited ROM following ECC in 
elbow flexors. The present study conflicts with previous 
results reported by Lenn et al. (2002). Although the type 
of exercise and target muscle in the present study were the 
same as that of the previous study (Lenn et al. 2002), larger 
doses of EPA were administered over a longer period in the 
present study. Further studies are needed on the effect of 
EPA and DHA on ROM, but the amelioration of limited 
ROM in response to ECC may depend on the dose and 
duration of the supplement regimen in addition to the type 
of exercise.
The DOMS of the brachialis in the EPA group at 3 days 
after ECC was significantly lower than that in the PL 
group, but the DOMS of the biceps brachii did not change. 
Although the reason for the difference between two mus-
cles is unclear, we suggest that the damage to ECC mainly 
occurred in the brachialis. The effect of EPA and DHA on 
DOMS remains controversial with previous studies arguing 
that there was a small number of subjects and large vari-
ability (DiLorenzo et al. 2014; Gray et al. 2014; Houghton 
and Onambele 2012; Jouris et al. 2011; Lenn et al. 2002; 
Tartibian et al. 2011). However, our result, which is lim-
ited in brachialis, demonstrates that EPA and DHA mitigate 
DOMS 3 days after ECC. The EPA and DHA supplementa-
tion alleviated damage in pain nerve endings, as discussed 
by a previous study (Cheung et al. 2003). In addition, since 
DOMS in brachioradialis did not change during experimen-
tal periods, brachioradialis might be a minor contributor in 
this ECC.
The present study demonstrated significantly lower 
increases in serum IL-6 levels at 3 days after exercise in the 
EPA group than in the PL group. Although no significant 
differences were observed between the two groups, there 
was a trend toward lower serum TNF-α levels and IL-6 
immediately after exercise in the EPA group than in the 
PL group. These tendencies suggest that an inflammatory 
response has  occurred immediately after exercise and then 
anti-inflammatory response has  occurred at 3 days. Oth-
erwise, IL-6 has been demonstrated as a marker of inflam-
mation with peak levels evident at 2 days after an eccentric 
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exercise injury and a return to basal values 7 days after 
exercise (Phillips et al. 2003). In this stage, although we 
cannot conclude whether IL-6 is an inflammatory or anti-
inflammatory response, we speculate that larger muscle 
damage had been induced in the PL group in comparison 
with the EPA group, because of the IL-6 activations of 
post-exercise and 3 days later.
Although serum levels of Mb, a marker of muscle dam-
age, significantly increased in the PL group, no significant 
changes in Mb levels were observed in the EPA group, and 
there were no significant differences between the groups. 
Further, no significant differences in serum CK levels were 
observed between the two groups. Serum Mb and CK are 
known markers that indicate large differences in individu-
als (Clarkson et al. 1992). In the present study, the results 
of serum Mb and CK levels also showed large standard 
deviations, especially in the PL group. Although the pre-
sent study was conducted in a parallel-group trial design 
because of “repeated bout effect” (Nosaka et al. 2005), 
the crossover design would have been more appropriate to 
minimize this effect. Therefore, these results were re-ana-
lyzed between the groups using logarithmic values of Mb 
and CK data because of heterogeneity of variance. This re-
analysis indicated significant differences in serum Mb lev-
els between the groups 3 days after ECC (data not shown). 
Although larger samples need to be used because of large 
individual differences, this result led us to suppose that 
EPA and DHA possess improvement on cellular membrane 
structure.
The time points of a significant difference between 
EPA and CON groups were different for each variable. We 
confirmed that no significant correlation between all mus-
cle damage markers at each time point was observed in 
this study (data not shown). Hence, these markers such as 
MVC, DOMS, ROM, serum CK, and Mb are considered 
to be independent indicators of muscle damage. Regard-
ing the time course of each parameter, we confirmed that 
decreases in MVC and ROM showed the peak at post-ECC, 
which was early phase, and relatively large effects with 
the EPA and DHA ingestion in comparison with the late 
phase phenomenon. These results are also similar to the 
previous studies (Chan et al. 2012; Chen et al. 2011). We 
assume that the EPA and DHA play a role in the protection 
of muscle cell membrane on the early phase. On the other 
hand, DOMS, CK, myoglobin, and IL-6 in the present 
study showed a peak at 3 days after ECC. These parameters 
were relatively small effects or there were no differences 
between the groups. We also speculate that EPA and DHA 
have little or indirect effect on the later phase.
Previous studies have reported the efficacy of either EPA 
or DHA or a combination of EPA and DHA supplementa-
tion on muscle damage (DiLorenzo et al. 2014; Houghton 
and Onambele 2012; Jouris et al. 2011; Lenn et al. 2002; 
Tartibian et al. 2011). Regarding DOMS, several papers 
including our study showed positive effects with EPA and 
DHA supplementation (Jouris et al. 2011; Tartibian et al. 
2011). However, it has been shown that the ingestion of 
a single DHA (DiLorenzo et al. 2014) or EPA (Houghton 
and Onambele 2012) had no effect on DOMS. Although 
the dose and period are different from the previous stud-
ies (Jouris et al. 2011; Tartibian et al. 2011), we suggest 
that the ingestion of both EPA and DHA, especially at 
the ratio of approximately 2:1, has a synergistic effect on 
DOMS attenuation. On the other hand, IL-6 was attenu-
ated by either single or simultaneous ingestion, but CK 
was decreased only by DHA and a combination of EPA 
and DHA (DiLorenzo et al. 2014; Houghton and Onambele 
2012; Tartibian et al. 2009, 2011). Hence, we also speculate 
that EPA and DHA might have different roles, and thereby 
simultaneous ingestion of EPA and DHA has a possible 
synergistic effect.
There are three limitations in the present study. First, 
we examined only a single dose and duration regimen of 
EPA and DHA administration in a single-exercise model. 
Regarding the effect of EPA and DHA supplementation on 
muscle damage, the minimal effect was with 540 mg/day 
(EPA and DHA) according to Tartibian et al. (2009). Hence, 
we have determined the amount of supplementation in con-
sideration of the minimal effect in addition to a physical 
burden of subjects. However, further investigation is needed 
to study the different doses of EPA and DHA to elucidate 
the appropriate amount. Second, both the amount and dura-
tion of the EPA and DHA regimen was different in previous 
studies. Therefore, it is unclear which the most important 
factor is (amount or period) in this study. Further study is 
required to investigate this point. Third, the degree of incor-
porated EPA and DHA in the blood is unclear because we 
did not measure the pre-supplementation of serum EPA and 
DHA. Hence, it is necessary to measure the serum EPA and 
DHA levels for understanding the blood inflow.
Conclusion
In summary, the present study investigated the efficacy of 
8 weeks EPA and DHA supplementation in reducing mus-
cle damage following eccentric contractions. The results 
showed that 600 mg/day EPA and 260 mg/day DHA sup-
plementation attenuated the reduction of muscle strength 
and limited ROM. Therefore, we concluded that supple-
mentation with EPA and DHA has a positive effect for 
these two symptoms of muscle damage. Further studies 
may need to investigate the synergistic and/or single, time, 
and dose effects of the supplementation.
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